XML 56 R44.htm IDEA: XBRL DOCUMENT v3.19.2
REVENUE (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue        
Revenue $ 1,287,624 $ 1,416,078 $ 2,544,432 $ 2,758,562
Manufacturer's rebates earned on total gross profit (in percent) 9.60% 22.30% 10.60% 14.80%
Inter-segment eliminations        
Revenue        
Revenue $ (18,458) $ (6,415) $ (27,932) $ (8,378)
Specialty        
Revenue        
Revenue 1,215,769 1,233,746 2,384,134 2,386,725
PBM        
Revenue        
Revenue 90,313 188,747 188,230 380,215
Oncology | Specialty        
Revenue        
Revenue 718,081 706,291 1,404,715 1,393,188
Specialty infusion | Specialty        
Revenue        
Revenue 192,156 181,250 370,604 346,967
Immunology | Specialty        
Revenue        
Revenue 140,836 142,952 276,528 278,551
Other | Specialty        
Revenue        
Revenue 164,696 203,253 332,287 368,019
Retail networks | PBM        
Revenue        
Revenue 57,784 146,127 125,196 291,288
Specialty pharmacy | PBM        
Revenue        
Revenue 18,070 23,001 34,167 45,314
Mail order | PBM        
Revenue        
Revenue 11,817 17,018 22,782 34,010
Other | PBM        
Revenue        
Revenue $ 2,642 $ 2,601 $ 6,085 $ 9,603